Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies
この論文をさがす
説明
Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) is a useful technique for acquiring both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened up a new field of clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, treatment optimization, re-staging, therapy monitoring, and prognostication of uterine and ovarian cancers as well as various malignant tumors. The present review discusses the current role of FDG-PET/CT in the management of gynecologic malignancies, focusing on its usefulness and limitations for imaging such patients.
収録刊行物
-
- Japanese Journal of Radiology
-
Japanese Journal of Radiology 32 (6), 313-323, 2014-04-18
Springer Science and Business Media LLC
